EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:747609 - irsenontrine

Default Structure
ChEBI IDCHEBI:747609
ChEBI Nameirsenontrine
Stars
DefinitionA phosphodiesterase 9 inhibitor, potential therapeutic approach for improving cognitive dysfunction in dementia, including in Alzheimer's disease or dementia with Lewy bodies.
Last Modified28 April 2026
SubmitterAnneNiknejad
DownloadsMolfile
FormulaC22H22N4O3
Net Charge0
Average Mass390.443
Monoisotopic Mass390.16919
SMILESCOc1ncc(C)c(-c2ccc3c(c2)nc(=O)c2cnn([C@H]4CCOC4)c23)c1C
InChIInChI=1S/C22H22N4O3/c1-12-9-23-22(28-3)13(2)19(12)14-4-5-16-18(8-14)25-21(27)17-10-24-26(20(16)17)15-6-7-29-11-15/h4-5,8-10,15H,6-7,11H2,1-3H3,(H,25,27)/t15-/m0/s1
InChIKeyCKJDCNZBABIEBZ-HNNXBMFYSA-N
Roles Classification
Application:
antiparkinson drug  A drug used in the treatment of Parkinson's disease.
ChEBI Ontology
Outgoing Relation(s)
irsenontrine (CHEBI:747609) has role antiparkinson drug (CHEBI:48407)
irsenontrine (CHEBI:747609) is a organic molecular entity (CHEBI:50860)
INN  Source
irsenontrineWHO MedNet
Synonyms  Source
E-2027ChEMBL
E2027DrugBank
ER-592221-00ChEMBL
Manual XrefsDatabases
D11955KEGG DRUG
DB19044DrugBank
Registry NumbersSources
CAS:1429509-82-9KEGG DRUG
Citations